Arcadia Biosciences (RKDA) Income towards Parent Company (2016 - 2024)
Historic Income towards Parent Company for Arcadia Biosciences (RKDA) over the last 11 years, with Q4 2024 value amounting to -$27000.0.
- Arcadia Biosciences' Income towards Parent Company rose 9875.63% to -$27000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$27000.0, marking a year-over-year increase of 9944.51%. This contributed to the annual value of -$2.7 million for FY2024, which is 6527.57% up from last year.
- According to the latest figures from Q4 2024, Arcadia Biosciences' Income towards Parent Company is -$27000.0, which was up 9875.63% from -$430000.0 recorded in Q3 2024.
- Arcadia Biosciences' 5-year Income towards Parent Company high stood at $7.6 million for Q4 2020, and its period low was -$13.8 million during Q4 2021.
- In the last 5 years, Arcadia Biosciences' Income towards Parent Company had a median value of -$2.1 million in 2023 and averaged -$3.5 million.
- In the last 5 years, Arcadia Biosciences' Income towards Parent Company skyrocketed by 22027.56% in 2020 and then crashed by 71546.96% in 2024.
- Quarter analysis of 5 years shows Arcadia Biosciences' Income towards Parent Company stood at $7.6 million in 2020, then plummeted by 281.77% to -$13.8 million in 2021, then surged by 91.68% to -$1.1 million in 2022, then crashed by 89.11% to -$2.2 million in 2023, then soared by 98.76% to -$27000.0 in 2024.
- Its Income towards Parent Company stands at -$27000.0 for Q4 2024, versus -$430000.0 for Q3 2024 and -$789000.0 for Q2 2024.